Patent details

Basic Information

Publication number:

EP1423391

PCT Application Number:

PCT/EP/2002/009663

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027975531

PCT Publication Number:

WO/2003/020721

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES

French Title of Invention:

PYRROLOPYRIMIDES EN TANT QU'AGENTS D'INHIBITION DE CYSTEINE PROTEASES

German Title of Invention:

PYRROLOPYRIMIDINE ALS MITTEL ZUR INHIBIERUNG VON CYSTEINPROTEASEN

SPC Number:

Dates

Filing date:

29/08/2002

Grant date:

17/05/2006

EP Publication Date:

17/05/2006

PCT Publication Date:

13/03/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/06/2004

EP B1 Publication Date:

17/05/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/08/2011

Expiration date:

29/08/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/09/2007

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1235 Vienna, Austria (AT)

Inventor

1

Name:

HAYAKAWA Kenji

Address:

Japan (JP)

2

Name:

TENO Naoki

Address:

Japan (JP)

3

Name:

IRIE Osamu

Address:

Japan (JP)

4

Name:

BETSCHART Claudia

Address:

Switzerland (CH)

5

Name:

LATTMANN René

Address:

Switzerland (CH)

6

Name:

IWASAKI Genji

Address:

Japan (JP)

7

Name:

MISSBACH Martin

Address:

Switzerland (CH)

8

Name:

SAKAKI Junichi

Address:

Japan (JP)

Priority

Priority Number:

0121033

Priority Date:

30/08/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 487/04;

Filing date	Document type	Number of pages